DrugPatentWatch Database Preview
Duvelisib - Generic Drug Details
» See Plans and Pricing
What are the generic sources for duvelisib and what is the scope of freedom to operate?
Duvelisib
is the generic ingredient in one branded drug marketed by Secura and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Duvelisib has one hundred and thirty-seven patent family members in thirty-one countries.
Summary for duvelisib
International Patents: | 137 |
US Patents: | 4 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Bulk Api Vendors: | 61 |
Clinical Trials: | 31 |
Patent Applications: | 827 |
Drug Prices: | Drug price trends for duvelisib |
What excipients (inactive ingredients) are in duvelisib? | duvelisib excipients list |
DailyMed Link: | duvelisib at DailyMed |
Recent Clinical Trials for duvelisib
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
John Kirkwood | Phase 1/Phase 2 |
Emory University | Phase 2 |
University of Pennsylvania | Phase 2 |
US Patents and Regulatory Information for duvelisib
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Secura | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-002 | Sep 24, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Secura | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-001 | Sep 24, 2018 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Secura | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-001 | Sep 24, 2018 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for duvelisib
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2011509259 | Start Trial |
South Korea | 101875720 | Start Trial |
South Korea | 20100126287 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |